Oral vs. Gut Probiotic Strains
Oral and gut probiotics use different strains because the two microbiomes have different physiology. Streptococcus salivarius K12/M18 and Lactobacillus reuteri target the mouth; Lactobacillus rhamnosus GG and Bifidobacterium spp. target the gut. Mixing them up wastes both.
Key Facts
- S. salivarius K12 colonizes the oropharynx and reduces strep throat recurrence
- L. reuteri lozenges reduce gingival bleeding and pocket depth in trials
- L. rhamnosus GG is one of the most studied gut probiotics for diarrhea prevention
- Bifidobacterium strains rarely survive transit unless enteric-coated
Why Strain Specificity Matters
Probiotic effects are strain-specific, not species-specific. L. reuteri DSM 17938 has different actions than L. reuteri ATCC 6475. Picking the wrong strain — or one not validated for your goal — usually means no effect at all.
Oral Strains Worth Knowing
S. salivarius K12 (BLIS K12) and M18 produce bacteriocins that suppress S. mutans (cavities) and S. pyogenes (strep throat). L. reuteri lozenges have multiple RCTs showing reduced gingivitis. These are best delivered as lozenges or chewables that dissolve in the mouth.
Gut Strains Worth Knowing
L. rhamnosus GG, Saccharomyces boulardii, and Bifidobacterium infantis have the strongest evidence for gut applications. These need to survive stomach acid, so capsule format and CFU dose matter.